These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

324 related items for PubMed ID: 31809606

  • 1. Effect of isotretinoin treatment on the inflammatory markers in patients with acne vulgaris: can monocyte/HDL be a new indicator for inflammatory activity of isotretinoin treatment?
    Kutlu Ö.
    Cutan Ocul Toxicol; 2020 Mar; 39(1):67-70. PubMed ID: 31809606
    [Abstract] [Full Text] [Related]

  • 2. Can monocyte/HDL show inflammatory activity of isotretinoin treatment in acne patients?
    Önder S, Ozturk M.
    Cutan Ocul Toxicol; 2020 Jun; 39(2):111-114. PubMed ID: 32100587
    [Abstract] [Full Text] [Related]

  • 3. Effect of isotretinoin treatment on inflammatory and hematological parameters in patients with acne vulgaris.
    Esen M.
    Cutan Ocul Toxicol; 2024 Mar; 43(1):27-32. PubMed ID: 37837334
    [Abstract] [Full Text] [Related]

  • 4. Investigation of systemic immune-inflammation index and systemic inflammation response index as an indicator of the anti-inflammatuary effect of isotretinoin in patients with acne vulgaris.
    Cosansu NC, Yuksekal G, Turan U, Umitfer F, Yaldiz M, Sevimli Dikicier B.
    Cutan Ocul Toxicol; 2022 Jun; 41(2):174-178. PubMed ID: 35658795
    [Abstract] [Full Text] [Related]

  • 5. Increases in uric acid and monocyte-high-density lipoprotein ratio as possible atherosclerotic indicators in acne patients using isotretinoin.
    Metin N, Turan Ç.
    J Cosmet Dermatol; 2021 Sep; 20(9):2945-2949. PubMed ID: 33387386
    [Abstract] [Full Text] [Related]

  • 6. A Novel Inflammatory Marker in the Follow-up of Moderate-to-Severe Acne Vulgaris Administered Isotretinoin: Systemic Immune-Inflammation Index (SII).
    Turan Ç, Metin N.
    Curr Health Sci J; 2022 Sep; 48(1):63-67. PubMed ID: 35911945
    [Abstract] [Full Text] [Related]

  • 7. Effect of oral doxycycline, azithromycin and isotretinoin on haematological inflammatory markers and interleukin-17A levels in acne vulgaris: a single blinded randomised interventional study.
    Agrawal A, Bhardwaj A, Singh S, Budania A, Bains A, Sharma S, Purohit A, Rajan M B, Rajagopal V.
    Arch Dermatol Res; 2024 Oct 17; 316(10):697. PubMed ID: 39417892
    [Abstract] [Full Text] [Related]

  • 8. Investigation of monocyte HDL ratio as an indicator of inflammation and complete blood count parameters in patients with acne vulgaris.
    Turkmen D, Altunisik N, Sener S.
    Int J Clin Pract; 2020 Dec 17; 74(12):e13639. PubMed ID: 32741037
    [Abstract] [Full Text] [Related]

  • 9. Is mean platelet volume an inflammatory marker in acne patients treated with isotretinoin?
    Tamer F, Yuksel ME, Avcı E.
    Acta Dermatovenerol Alp Pannonica Adriat; 2019 Jun 17; 28(2):65-69. PubMed ID: 31233169
    [Abstract] [Full Text] [Related]

  • 10. Effects of isotretinoin on the inflammatory markers and the platelet counts in patients with acne vulgaris.
    Seçkin HY, Baş Y, Takçı Z, Kalkan G.
    Cutan Ocul Toxicol; 2016 Jun 17; 35(2):89-91. PubMed ID: 25853176
    [Abstract] [Full Text] [Related]

  • 11. Can monocyte to HDL cholesterol ratio and monocyte to lymphocyte ratio be markers for inflammation and oxidative stress in patients with vitiligo? A preliminary study.
    Demirbaş A, Elmas ÖF, Atasoy M, Türsen Ü, Lotti T.
    Arch Dermatol Res; 2021 Aug 17; 313(6):491-498. PubMed ID: 32816078
    [Abstract] [Full Text] [Related]

  • 12. Correlation between depression scores and serum NF-ĸB/NLRP3 axis, biotinidase, and HMGB1 after treatment with isotretinoin in patients with acne vulgaris.
    Binsaleh AY, Ali LS, Bahaa MM, Elmasry TA, Negm WA, Hamouda AO, Salahuddin MM, Wahsh E, El-Samongy MA, Alsubaie N, El-Khateeb E, Yasser M, Eltantawy N.
    J Cosmet Dermatol; 2024 Oct 17; 23(10):3409-3417. PubMed ID: 38923374
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of hematological parameters in patients using systemic isotretinoin with diagnosis of acne vulgaris.
    Demirci Saadet E, Sahin U.
    J Cosmet Dermatol; 2023 Mar 17; 22(3):1077-1082. PubMed ID: 36437707
    [Abstract] [Full Text] [Related]

  • 14. Treatment outcome of acne vulgaris with oral isotretinoin.
    Bener A, Lestringant GG, Ehlayel MS, Saarinen K, Takiddin AH.
    J Coll Physicians Surg Pak; 2009 Jan 17; 19(1):49-51. PubMed ID: 19149981
    [Abstract] [Full Text] [Related]

  • 15. Combined Low-Dose Isotretinoin and Pulsed Dye Laser Versus standard-Dose Isotretinoin in the Treatment of Inflammatory Acne.
    Ibrahim SM, Farag A, Hegazy R, Mongy M, Shalaby S, Kamel MM.
    Lasers Surg Med; 2021 Jul 17; 53(5):603-609. PubMed ID: 33185932
    [Abstract] [Full Text] [Related]

  • 16. Isotretinoin treatment induces oxidative toxicity in blood of patients with acne vulgaris: a clinical pilot study.
    Erturan İ, Naziroğlu M, Akkaya VB.
    Cell Biochem Funct; 2012 Oct 17; 30(7):552-7. PubMed ID: 22517509
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Vitamin D levels in acne vulgaris patients treated with oral isotretinoin.
    El-Hamd MA, El Taieb MA, Ibrahim HM, Aly SS.
    J Cosmet Dermatol; 2019 Feb 17; 18(1):16-20. PubMed ID: 29460332
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of peripheral lymphocyte subsets in acne vulgaris patients before and after systemic isotretinoin treatment.
    Gunaydin SD, Tezcan I.
    Indian J Pharmacol; 2022 Feb 17; 54(5):338-344. PubMed ID: 36537402
    [Abstract] [Full Text] [Related]

  • 20. Plasma dermcidin levels in acne patients, and the effect of isotretinoin treatment on dermcidin levels.
    Alatas ET, Kara Polat A, Kalayci M, Dogan G, Akin Belli A.
    Dermatol Ther; 2019 Sep 17; 32(5):e13044. PubMed ID: 31364786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.